Badanie fazy III leku TAK-999: Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein